1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. ABclonal Biotechnology Acquires Yurogen Biosystems

M&A Deal Summary

ABclonal Biotechnology Acquires Yurogen Biosystems

On March 5, 2021, ABclonal Biotechnology acquired life science company Yurogen Biosystems

Acquisition Highlights
  • This is ABclonal Biotechnology’s 1st transaction in the Life Science sector.
  • This is ABclonal Biotechnology’s 1st transaction in the United States.
  • This is ABclonal Biotechnology’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2021-03-05
Target Yurogen Biosystems
Sector Life Science
Buyer(s) ABclonal Biotechnology
Deal Type Add-on Acquisition

Target

Yurogen Biosystems

Worcester, Massachusetts, United States
Yurogen Biosystems LLC is a contract research organization (CRO) dedicated to monoclonal antibody discovery in biopharma and biotech sectors. Yurogen Biosystems was founded in 2014 and is based in Worcester, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ABclonal Biotechnology

Wuhan, China
Category Company
Sector Life Science
DESCRIPTION

ABclonal Biotechnology is a global life science tools and services provider. ABclonal Biotechnology was founded in 2011 and is based in Wuhan, China.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal